Table of Contents
Washington University Experience | NEOPLASMS (GLIAL) | PLNTY | 2E2 PLNTY (Case 2, Resection 2) CD34 20X 2
There is considerable variation of CD34 immunoreactivity within the tumor ranging from wispy to strong cell bodies and processes. (CD34 IHC)